Had a battery problem in JT and only got one shot not worth bothering with. Busy with a speech tomorrow on the Forest Service Adventure Pass, my Mom just broke a wrist, I've been furniture shopping (having just moved to a bigger place), and two of my close friends are moving . . .
So just doing some trading and cutting and pasting for now.
These developments with Pfizer announced of late bode well for AGNT:
>>FOSTER CITY, Calif., Nov 5, 2001 (BW HealthWire) -- Argonaut Technologies, Inc. (Nasdaq: AGNT chart, msgs) announced today the formation of a new consortium comprised of two major pharmaceutical and specialty chemical companies with the goal of developing a state-of-the-art, multi-channel synthesizer for chemical process optimization. Joining in the collaboration are Pfizer Inc. and ICI PLC.
Argonaut's new process chemistry system will be designed to deliver a fully automated process development solution, with the flexibility and ease of a manual device. Each participating company may receive one or more of the fully automated advanced process development tools at the end of the collaboration.
This consortium represents Argonaut's fifth product development consortium. Consortium members provide expert advice to define new instrument specifications and to test and validate initial versions of the product design. Previous collaborations have resulted in the development and commercialization of Argonaut's Trident(TM) Automated Library Synthesizer, as well as the Surveyor(TM).
"We are excited about working with these world-class organizations and their leading chemists to define the next generation of process development instruments," said Lissa Goldenstein, Argonaut's president and CEO. "Consortium members' input is vital to our development process and helps ensure that Argonaut meets the needs of our customers right from the start. Our previous consortia have proven that this methodology produces better, more cost-effective products for the market."
"This new process chemistry system hopes to combine the parallel throughput of our Surveyor with the control and analytical capabilities of our CLARK(TM)," said Dennis Dye, Argonaut's vice president of instrumentation. "One of the features anticipated to be integrated into this tool is in-situ analytical techniques under pilot plant-like conditions. This may help our customers refine and perfect their processes before they spend large amounts of money on physical plant and equipment."
"The Argonaut consortium provides ICI with a unique opportunity to help develop a state-of-the-art computerized, multi-reactor unit for synthesizing polymers at a useful scale for screening purposes," according to Stephen Downing, strategic research manager at ICI Paints. "Argonaut has thought quite deeply about the design of both the hardware and software and is listening to the customer's needs for combining functionality, capability and user-friendliness at an affordable cost. This new system should automate current processes and generate useful data for developing new formulations and processes."<<
snip
Cheers, Tuck |
